Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENXQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,164
Award facts
- Contract value 100% obligated
- $16,163.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,163.94 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a purchase under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is the sole awardee, with no identified subcontractor relationships.
This delivery order falls under DMS Pharmaceutical Group's single-award IDC established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceuticals to Department of Defense healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, carries a $500 million ceiling value and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. The delivery order authorizes procurement of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support recurring medical supply needs across the global military healthcare system. DMS Pharmaceutical Group's established performance on numerous prior delivery orders and its comprehensive product portfolio demonstrate its critical role as a regional pharmaceutical supplier for Department of Defense operations.
Quick answers
Who was awarded contract SPE2DU26FENXQ?
SPE2DU26FENXQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DU26FENXQ worth?
The government has obligated $16,164 on SPE2DU26FENXQ.
Is contract SPE2DU26FENXQ an order under another contract?
Yes. SPE2DU26FENXQ is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXQ competed?
The extent of competition for SPE2DU26FENXQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award